MERKEL CELL CARCINOMA, STAGE I

Clinical trials for MERKEL CELL CARCINOMA, STAGE I explained in plain language.

Never miss a new study

Get alerted when new MERKEL CELL CARCINOMA, STAGE I trials appear

Sign up with your email to follow new studies for MERKEL CELL CARCINOMA, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug tested to stop rare skin cancer from spreading

Disease control Not yet recruiting

This study is testing whether a drug called cemiplimab, given before surgery, can help control early-stage Merkel cell carcinoma, a rare and aggressive skin cancer. It will involve about 135 adults whose main tumor has been removed but who are still waiting for a lymph node biops…

Matched conditions: MERKEL CELL CARCINOMA, STAGE I

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

MERKEL CELL CARCINOMA, STAGE I

Get alerted when new MERKEL CELL CARCINOMA, STAGE I trials appear

New drug tested to stop rare skin cancer from spreading